FDA ISSUES FAQ GUIDANCE FOR CGMP FOR PET DRUGS

UPDATE: FDA has posted new draft guidance – FDA Oversight of PET Drug Products, Questions and Answers.

FDA has published a revised version of the FAQ guidance initially published on the agency’s website on February 2, 2012. The guidance is intended to help producers of PET drugs meet the requirements for FDA’s drug approval process. This guidance provides questions and answers that address nearly all aspects of the drug regulatory process, including application, submission, review, compliance with CGMPs, inspections, registration and listing and user fees.

The guidance is available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/
Guidances/UCM290024.pdf

Comments and suggestions regarding this draft document should be submitted either electronically or written documents by May 29, 2012.

Advertisements
This entry was posted in PET Drugs. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s